tiprankstipranks
Appili Therapeutics Signs Definitive Agreement  to be Acquired by Aditxt, Inc.
PremiumPress ReleasesAppili Therapeutics Signs Definitive Agreement to be Acquired by Aditxt, Inc.
27d ago
Appili Therapeutics announces publication of manuscript on tularemia outbreaks
PremiumThe Fly
Appili Therapeutics announces publication of manuscript on tularemia outbreaks
2M ago
Appili Therapeutics Advances Tularemia Vaccine
PremiumCompany Announcements
Appili Therapeutics Advances Tularemia Vaccine
2M ago
Appili Therapeutics announces U.S. FDA approval of LIKMEZ
PremiumThe FlyAppili Therapeutics announces U.S. FDA approval of LIKMEZ
7M ago
Is APLIF a Buy, Before Earnings?
PremiumPre-Earnings
Is APLIF a Buy, Before Earnings?
9M ago
Appili appoints Gelhaus, Baran as Directors to support ATi-1701 program
PremiumThe Fly
Appili appoints Gelhaus, Baran as Directors to support ATi-1701 program
1y ago
Appili announces Notice of Allowance from USPTO for ATI-1501 patent
PremiumThe FlyAppili announces Notice of Allowance from USPTO for ATI-1501 patent
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100